No.
|
Content
|
|
|
Executive summary
|
|
|
Introduction & methodology
|
|
1
|
Overview of pyrethroids industry in China
|
|
1.1
|
Definition and classification of pyrethroids
|
|
1.2
|
Development history of pyrethroids industry in China
|
|
1.3
|
Position of pyrethroids in Chinese insecticide industry
|
|
2
|
Supply and demand of pyrethroids in China
|
|
2.1
|
Summary of supply and demand
|
|
2.1.1
|
Supply summary (capacity & output, key producers), 2015–2019
|
|
2.1.2
|
Demand summary (volume & value, application areas), 2015–2019
|
|
2.2
|
Supply and demand of key products
|
|
2.2.1
|
Lambda-cyhalothrin
|
|
2.2.1.1
|
Registration
|
|
2.2.1.2
|
Production situation, 2015–2019
|
|
2.2.1.3
|
Export situation, 2017–2019
|
|
2.2.1.4
|
Price, 2015–2020
|
|
2.2.1.5
|
Consumption situation, 2015–2019
|
|
2.2.1.6
|
Outlook, 2020–2024
|
|
2.2.2
|
Bifenthrin
|
|
2.2.2.1
|
Registration
|
|
2.2.2.2
|
Production situation, 2015–2019
|
|
2.2.2.3
|
Export situation, 2017–2019
|
|
2.2.2.4
|
Price, 2015–2020
|
|
2.2.2.5
|
Consumption situation, 2015–2019
|
|
2.2.2.6
|
Outlook, 2020–2024
|
|
2.2.3
|
Deltamethrin
|
|
2.2.3.1
|
Registration
|
|
2.2.3.2
|
Production situation, 2015–2019
|
|
2.2.3.3
|
Export situation, 2017–2019
|
|
2.2.3.4
|
Price, 2015–2020
|
|
2.2.3.5
|
Consumption situation, 2015–2019
|
|
2.2.3.6
|
Outlook, 2020–2024
|
|
2.2.4
|
Cypermethrin
|
|
2.2.4.1
|
Registration
|
|
2.2.4.2
|
Production situation, 2015–2019
|
|
2.2.4.3
|
Export situation, 2017–2019
|
|
2.2.4.4
|
Price, 2015–2020
|
|
2.2.4.5
|
Consumption situation, 2015–2019
|
|
2.2.4.6
|
Outlook, 2020–2024
|
|
2.2.5
|
Fenpropathrin
|
|
2.2.5.1
|
Registration
|
|
2.2.5.2
|
Production situation, 2015–2019
|
|
2.2.5.3
|
Export situation, 2017–2019
|
|
2.2.5.4
|
Price, 2018–2020
|
|
2.2.5.5
|
Consumption situation, 2015–2019
|
|
2.2.5.6
|
Outlook, 2020–2024
|
|
2.2.6
|
Permethrin
|
|
2.2.6.1
|
Registration
|
|
2.2.6.2
|
Production situation, 2015–2019
|
|
2.2.6.3
|
Export situation, 2017–2019
|
|
2.2.6.4
|
Price, 2018–2020
|
|
2.2.6.5
|
Consumption situation, 2015–2019
|
|
2.2.6.6
|
Outlook, 2020–2024
|
|
2.2.7
|
Fenvalerate
|
|
2.2.7.1
|
Registration
|
|
2.2.7.2
|
Production situation, 2015–2019
|
|
2.2.7.3
|
Export situation, 2017–2019
|
|
2.2.7.4
|
Price, 2015–2020
|
|
2.2.7.5
|
Consumption situation, 2015–2019
|
|
2.2.7.6
|
Outlook, 2020–2024
|
|
2.2.8
|
Esfenvalerate
|
|
2.2.8.1
|
Registration
|
|
2.2.8.2
|
Production situation, 2015–2019
|
|
2.2.8.3
|
Export situation, 2017–2019
|
|
2.2.8.4
|
Price, 2015–2020
|
|
2.2.8.5
|
Consumption situation, 2015–2019
|
|
2.2.8.6
|
Outlook, 2020–2024
|
|
2.2.9
|
Cyfluthrin
|
|
2.2.9.1
|
Registration
|
|
2.2.9.2
|
Production situation, 2015–2019
|
|
2.2.9.3
|
Export situation, 2017–2019
|
|
2.2.9.4
|
Price, 2015–2020
|
|
2.2.9.5
|
Consumption situation, 2015–2019
|
|
2.2.9.6
|
Outlook, 2020–2024
|
|
2.2.10
|
Beta-cypermethrin
|
|
2.2.10.1
|
Registration
|
|
2.2.10.2
|
Production situation, 2015–2019
|
|
2.2.10.3
|
Export situation, 2017–2019
|
|
2.2.10.4
|
Price, 2015–2020
|
|
2.2.10.5
|
Consumption situation, 2015–2019
|
|
2.2.10.6
|
Outlook, 2020–2024
|
|
3
|
Key factors influencing development of pyrethroids
|
|
3.1
|
Governmental policies
|
|
3.2
|
Economic factors
|
|
3.3
|
Social environment
|
|
3.4
|
Industry competition
|
|
3.5
|
Production technology
|
|
4
|
Supply & demand forecast, 2020–2024
|
|
5
|
Risk assessment and market opportunities
|